These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 434647)

  • 21. Cellular fatty acid composition of WIGA, a rickettsia-like agent similar to the Legionnaires disease bacterium.
    Moss CW; Dees SB
    J Clin Microbiol; 1979 Sep; 10(3):390-1. PubMed ID: 489728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The morphology of the Legionnaires' disease organism.
    Katz SM
    Am J Pathol; 1978 Mar; 90(3):701-22. PubMed ID: 629329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of ergosterol and 3-hydroxy fatty acids in settled house dust by gas chromatography-mass spectrometry: comparison with fungal culture and determination of endotoxin by a Limulus amebocyte lysate assay.
    Saraf A; Larsson L; Burge H; Milton D
    Appl Environ Microbiol; 1997 Jul; 63(7):2554-9. PubMed ID: 9212406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth, survival, and resistance of the Legionnaires' disease bacterium.
    Wang WL; Blaser MJ; Cravens J; Johnson MA
    Ann Intern Med; 1979 Apr; 90(4):614-8. PubMed ID: 571258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endotoxicity of newly recognized gram negative organism: a collective review.
    Fumarola D
    Boll Ist Sieroter Milan; 1985; 64(4):255-61. PubMed ID: 3907664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology and immunopathology of Legionnaires' disease.
    Ward PA
    Ann Intern Med; 1979 Apr; 90(4):506-8. PubMed ID: 434626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a new serotype of legionnaires' disease bacterium.
    Edelstein PH; Meyer RD; Finegold SM
    Lancet; 1978 Dec; 2(8101):1172-4. PubMed ID: 82141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of beta-hydroxy fatty acids as chemical marker molecules for bacterial endotoxin by gas chromatography-mass spectrometry.
    Maitra SK; Nachum R; Pearson FC
    Appl Environ Microbiol; 1986 Sep; 52(3):510-4. PubMed ID: 3094448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of 3-hydroxy fatty acids as environmental markers of endotoxin using liquid chromatography coupled to tandem mass spectrometry.
    Uhlig S; Negård M; Heldal KK; Straumfors A; Madsø L; Bakke B; Eduard W
    J Chromatogr A; 2016 Feb; 1434():119-26. PubMed ID: 26818235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic findings in guinea pigs inoculated intraperitoneally with the Legionnaires' disease bacterium.
    Chandler FW; McDade JE; Hicklin MD; Blackmon JA; Thomason BM; Ewing EP
    Ann Intern Med; 1979 Apr; 90(4):671-5. PubMed ID: 373550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid demonstration of Legionella pneumophila in unembedded tissue. An adaptation of the Giménez stain.
    Greer PW; Chandler FW; Hicklin MD
    Am J Clin Pathol; 1980 Jun; 73(6):788-90. PubMed ID: 6156594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and properties of cyanobacterial endotoxins.
    Keleti G; Sykora JL
    Appl Environ Microbiol; 1982 Jan; 43(1):104-9. PubMed ID: 6798930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol infectivity of Legionella pneumophila.
    Zimmerman L
    N Engl J Med; 1979 Nov; 301(18):1004. PubMed ID: 492217
    [No Abstract]   [Full Text] [Related]  

  • 34. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.
    McDade JE; Shepard CC; Fraser DW; Tsai TR; Redus MA; Dowdle WR
    N Engl J Med; 1977 Dec; 297(22):1197-203. PubMed ID: 335245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine.
    Wong KH; Schalla WO; Arko RJ; Bullard JC; Feeley JC
    Ann Intern Med; 1979 Apr; 90(4):634-8. PubMed ID: 86314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
    Pool EJ; Johaar G; James S; Petersen I; Bouic P
    J Immunoassay; 1999; 20(1-2):79-89. PubMed ID: 10225516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of Legionnaires' disease.
    Carrington CB
    Ann Intern Med; 1979 Apr; 90(4):496-9. PubMed ID: 86311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of legionnaires' disease organism in Cambridge.
    Nagington J; Smith D; Wreghitt TG
    Lancet; 1978 Nov; 2(8100):1144-5. PubMed ID: 82697
    [No Abstract]   [Full Text] [Related]  

  • 39. Electron microscopy of the organism of Legionnaires' disease.
    Rodgers FG; Macrae AD; Lewis MJ
    Nature; 1978 Apr; 272(5656):825-6. PubMed ID: 643073
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the limulus amebocyte lysate test and gas chromatography-mass spectrometry for measuring lipopolysaccharides (endotoxins) in airborne dust from poultry-processing industries.
    Sonesson A; Larsson L; Schütz A; Hagmar L; Hallberg T
    Appl Environ Microbiol; 1990 May; 56(5):1271-8. PubMed ID: 2187411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.